An interview with Jürgen Eck CEO BRAIN AG, the Most Innovative Bioeconomy CEO 2018
Interview by Il Bioeconomista, 7 January 2019View article
Since February 2016, BRAIN AG is listed – as the first German company from the field of bioeconomy – in the Prime Standard segment of the Frankfurt stock exchange.
BRAIN AG is one of Europe’s leading technology companies in the field of industrial biotechnology, the core discipline of bioeconomy. From its proprietary BioArchive the Company identifies previously untapped, efficient enzymes, microbial producer organisms and bioactive natural substances in order to put them into industrial use. The resulting innovative product solutions are successfully applied in the chemical industry as well as in the consumer goods, cosmetics, animal feed, and food industries.
Please find information on BRAIN shares here. For further information visit the homepage of Deutsche Börse.
We want to provide ongoing and comprehensive information to all our shareholders. In this section you find our Adhoc News, Corporate News, Directors’ Dealings and Voting Rights.
Here you can download the BRAIN interim financial statements, our half-yearly and annual reports.
Next event: 30.08.2019 – Publication of the quarterly statement as of 30.06.2019 (9M)
Please register here if you wish to receive the most recent investor relations information about BRAIN AG via email.